glycopyrrolate has been researched along with trihexyphenidyl in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Heathcote, BV; Parry, M | 1 |
| Andrade, C; Bambole, V; Bang, A; Shah, N; Sonavane, S | 1 |
| Guzys, AT; Reddihough, DS; Reid, SM; Westbury, C | 1 |
3 other study(ies) available for glycopyrrolate and trihexyphenidyl
| Article | Year |
|---|---|
Pirenzepine selectively inhibits gastric acid secretion: a comparative pharmacological study between pirenzepine and seven other antiacetylcholine drugs.
Topics: Acetylcholine; Animals; Atropine; Benzilates; Benzodiazepinones; Dose-Response Relationship, Drug; Gastric Acid; Glycopyrrolate; Male; Mice; Piperazines; Pirenzepine; Propantheline; Pupil; Pyrimidines; Quaternary Ammonium Compounds; Rats; Trihexyphenidyl | 1980 |
Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness.
Topics: Adolescent; Anti-Dyskinesia Agents; Antipsychotic Agents; Atropine; Benzodiazepines; Blindness, Cortical; Electroconvulsive Therapy; Female; Glycopyrrolate; Haloperidol; Humans; Muscarinic Antagonists; Olanzapine; Panic; Schizophrenia, Paranoid; Treatment Outcome; Trihexyphenidyl | 2012 |
Anticholinergic medications for reducing drooling in children with developmental disability.
Topics: Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Developmental Disabilities; Female; Glycopyrrolate; Humans; Infant; Male; Scopolamine; Sialorrhea; Treatment Outcome; Trihexyphenidyl | 2020 |